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Abstract
Background: Tick-borne lymphadenopathy (TIBOLA) was first described in 1997 in a patient in France. The
causative agent, Rickettsia slovaca, is transmitted by Dermacentor ticks.
Case presentation: In southwestern Germany we encountered a patient with a tick bite at the dorsal scalp that
resulted in an eschar and nuchal lymphadenopathy. Additionally, fever, malaise as well as elevated inflammatory
markers and transaminases occurred. The characteristic clinical picture along with positive antibody testing for
rickettsiae of the tick-borne spotted fever group strongly suggest the diagnosis TIBOLA.
Conclusion: Human rickettsioses are emerging infections. Clinicians should be aware of TIBOLA as a newly
described rickettsial disease. As in our case, TIBOLA may be encountered in regions/countries where R. slovaca and
Dermacentor ticks are prevalent but autochthonous acquisition was not described before.
Background
Rickettsiae are obligate intracellular gram negative bac-
teria transmitted in the natural environment by vectors
such as ticks, fleas, lice, and mites. Of medical impor-
tance are Rickettsiae of the typhus group (R. prowazekii,
R. typhi) and Rickettsiae of the tick-borne spotted fever
group (e.g. R. rickettsii, R. conorii, R. africae), which now
compromises more than 20 different species as several
new species have been identified in recent years [1].
Tick-borne lymphadenopathy (TIBOLA) was first
described in 1997 in a female patient in France and is
defined as the association of a tick bite resulting in an
inoculation eschar on the scalp and enlargened cervical
lymphnodes in the absence of a rash [2]. Although the
causative agent of TIBOLA, Rickettsia slovaca,i sp r e v a -
lent in Dermacentor ticks in Germany, until 2009 no
case of TIBOLA has been described. Here we report the
first case of TIBOLA acquired in Germany.
Case presentation
In February 2009, a 67-year-old female patient sought
medical advice one week after suffering from a tick
bite at the dorsal scalp. She had acquired the tick in
southern Germany in the vicinity of Freiburg (Baden-
Wuerttemberg). Two days after removal of the tick she
noticed redness followed by ulcer formation at the bit-
ing site along with swollen regional lymph nodes. She
presented with high fever (40°C), malaise, headache
and nuchal lymphadenopathy. At the site of the tick
bite an eschar with edematous margins was present
( F i g u r e1 ) .T h er e m a i n i n gphysical examination was
unremarkable. She denied animal contacts and had not
been anywhere else than in the vicinity of Freiburg.
Laboratory investigations revealed a white blood cell
count of 8.3 × 10
9/L, C-reactive protein of 112 mg/L
(normal < 5 mg/L), moderately elevated transaminases
(ALT 133 U/L [normal < 35 U/L], AST 99 U/L [< 35
U/L], g-GT 158 U/L [< 40 U/L]) and mildly elevated
LDH (314 U/L [< 214 U/L]). Blood cultures were nega-
tive and cultures of dermal swabs obtained from the
eschar revealed normal skin flora. Computed tomogra-
phy revealed imbibition of the subcutaneous tissue
underneath the eschar (Figure 2) and non-necrotizing
lymphadenitis of the draining lymph nodes without
evidence of cervical or mediastinal abscess formation
(Figure 3). Antibody testing for Francisella tularensis,
Borrelia burgdorferi, Rickettsia prowazekii, Rickettsia
typhi and Yersinia enterocolitica was negative. She was
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ciprofloxacin, three days after initiation of antibiotic
treatment defervescence and clinical improvement
could be noticed.
In serial serum samples (day 7, 17 and 24) speci-
f i ca n t i b o d yt e s t i n gf o rr i c kettsiae of the tick-borne
spotted fever group revealed a seroconversion (indirect
immunofluorescence assay (Figure 4): R. conorii IgG
[Fuller Laboratories], <1:32, 1:512, 1:1024, respectively;
R. helvetica IgG [in house], <1:32, 1:32, 1:128, respec-
tively). Skin-biopsy of the eschar was not performed.
The patient recovered without further complications, a
change to specific anti-rickettsial antibiotic therapy, i.e.
doxycylin was not necessary.
Human rickettsioses occur worldwide and are consid-
ered to be emerging infections [3]. One of the newly dis-
covered rickettsial diseases is tick-borne lymphadenopathy
(TIBOLA). The causative agent, Rickettsia slovaca,w a s
Figure 1 Inoculation eschar.A6 7 - y e a ro l dw o m a nw i t ha n
inoculation eschar with central necrosis, edematous margins and
erythematous halo at the former site of the tick bite.
Figure 2 Head computed tomography scan. Imbibition of
subcutaneous tissue underneath the eschar (arrow).
Figure 3 Neck computed tomography scan. Non-necrotizing
lymphadenitis (arrow) along the draining lymph nodes without
evidence of cervical or mediastinal abscess formation (courtesy of
Mathias Langer, University Hospital Freiburg, Germany).
Figure 4 Indirect immunofluorescence assay using R. conorii
(dilution 1:256).
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as non-pathogenic until 1997 [2,4]. R. slovaca is trans-
mitted almost exclusively by Dermacentor marginatus and
rarely by Dermacentor reticulatus ticks (Figure 5).
Here we report the case of a female Caucasian patient
presenting with the characteristic clinical features of
TIBOLA. In our patient the tick was not available for
genus and species identification, however, the season
late winter/early spring and the localisation of the tick
b i t eo nt h es c a l ps t r o n g l ys u g g e s tab i t ed u et oD. mar-
ginatus which is prevalent in the vicinity of Freiburg.
Noteworthy, TIBOLA is one of the rare tick-borne dis-
e a s e st h a ti sm o r ec o m m o ni nt h ec o l ds e a s o n .A s
reported in several case series, females are at higher risk
of TIBOLA, the mean age is 30-35 years with a substan-
tial proportion of cases occurring in children. Apart
from TIBOLA, two other acronyms were proposed for
this clinical entity: Dermacentor-borne necrosis
erythema and lymphadenopathy (DEBONEL) or scalp
eschar and neck lymphadenopathy after tick bite (SEN-
LAT) [5].
R. slovaca has been described in Dermacentor ticks in
many European countries including France, Greece,
Hungary, Spain, Italy, Switzerland, Austria, Russia,
Ukraine, Armenia, and others. In Germany, R. slovaca
has been found in D. marginatus ticks in Baden-Wuert-
temberg in the area of the Rhine valley [6] and recently
in the Main valley in the vicinity of Aschaffenburg,
Bavaria [7].
Within the last years, detection of R. slovaca from
human cases has been increasingly reported from France,
Hungary, Spain and Italy [4,8-10]. It is remarkable that
although R. slovaca was isolated in ticks in Germany
already 30 years ago, no human case of TIBOLA in
Germany has been described until recently. As a conse-
quence of the case presented here and another case of
2009 from southern Rhineland-Palatinate [7], Germany
must be added to the list of countries where autochtho-
nous acquisition of TIBOLA has occurred. R. slovaca
infections seem to be more widespread over Germany as
has been found so far since our case was several hundred
kilometers south of the case described in Rhineland-Pala-
tinate. Including the recently described detection of Rick-
ettsia aeschlimannii, up to now seven rickettsial species
have been reported in Germany [11].
Apart from R. slovaca, the rickettsial genotypes RpA4,
DnS14 and DnS28 belonging to a new spotted fever
group species recently named R. raoultii have been
implicated in the etiology of TIBOLA [12]. Due to only
minor antigenetic differences among all spotted fever
group rickettsiae, serology is not able to discriminate
within members of this group and unambiguous (sub)
species-specific diagnosis can only be made by PCR
from skin biopsies or swab specimen of the eschar [13].
As R. raoultii is prevalent in D. reticulatis ticks in
southern Germany and skin biopsy/PCR was not per-
formed, we cannot rule out TIBOLA due to R. raoultii.
However, our patient suffered from high fever and pro-
nounced malaise. This strongly favours an infection due
to R. slovaca since R. raoultii is considered to be less
pathogenic and to cause a milder form of TIBOLA
[12,14].
Noteworthy, apart from fever and malaise our patient
presented with moderately elevated transaminases indi-
cating hepatic involvement in the course of infection.
Further evaluation included abdominal/hepatic ultraso-
nography which was unremarkable. Antibody testing for
Coxiella burnetii was negative. Improvement of ALT/
AST during antibiotic treatment argues against drug
induced hepatitis due to ampicillin/sulbactam or
ciprofloxacin.
The differential diagnosis in patients with an eschar
includes rickettsial infections, cutaneous anthrax, tular-
aemia, necrotic arachnidism (brown recluse spider bite),
scrub typhus (Orientia tsutsugamushi), rat bite fever
(Spirillum minus), staphylococcal or streptococcal
ecthyma, and, as discussed recently, infection due to
Bartonella henselae [5]. However, in the context of a
previous tick bite, infection due to Francisella tularensis,
or possibly B. henselae,a sw e l la ss t a p h y l o c o c c a lo r
streptococcal superinfection occur as most likely
diagnoses.
As for other rickettsioses the treatment of choice is
considered to be a 7 to 10 day course of doxycycline
(100 mg twice daily for adults), with ciprofloxacin or
azithromycin/clarithromycin as possible alternative
Figure 5 Adult Dermacentor spp.t i c k sa r ev e c t o r so fR. slovaca
and R. raoultii. D. marginatus and D. reticulatus tick bites are
preferentially located in the scalp region, the majority of tick bites
occur during the colder months. R. slovaca and R. raoultii are
maintained within Dermacentor spp. by transovarial and transstadial
transmission (courtesy of Heinz Mehlhorn, Duesseldorf University,
Germany).
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sis (e.g. epidemic typhus, Rocky Mountain Spotted
Fever, Mediterranean Spotted Fever) have not been
described in TIBOLA so far.
Conclusions
Our knowledge on geographic distribution, epidemiol-
ogy and ecology of rickettsiae is currently evolving. The
prevalence of rickettsial diseases in Germany and else-
where is probably underestimated. TIBOLA should be
noticed as an emerging infection, partly due to an
increasing spread of Dermacentor marginatus ticks.
Clinicians should be aware of TIBOLA as a tick-borne
disease as well as of the local prevalence of rickettsial
species and their potential vectors. In typical cases (as in
the patient reported here) awareness of TIBOLA enables
a rather reliable clinical diagnosis that typically results
in incisive diagnostic approaches and simple, unexpen-
sive treatment.
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